APOLLOHOSPNSEApollo Hospitals Enterprise Limited· MiscellaneousLowNeutral
Announced Sat, 30 Aug · 12:32 IST

Apollo Hospitals Enterprise Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 29, 2025. Further, the company has informed the Exchange regarding voting results.

Board & Shareholder Meetings View source PDF

APOLLOHOSP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Apollo Hospitals has submitted the voting results and scrutinizer's report for its 44th Annual General Meeting held on August 29, 2025, conducted via video conferencing. All 10 resolutions put to shareholders were duly approved with the requisite majority. These included adoption of FY25 financial statements, confirmation of interim dividend and declaration of final dividend, re-appointment of Ms. Shobana Kamineni as non-executive director, re-appointments of three executive directors — Preetha Reddy (Executive Vice Chairperson), Suneeta Reddy (Managing Director), and Sangita Reddy (Joint Managing Director) — each for a five-year term from February 2026, and re-appointment of Som Mittal as Independent Director. Shareholders also approved the appointment of Lakshmmi Subramanian & Associates as Secretarial Auditors for five years, ratified the Cost Auditor's remuneration, and cleared a special resolution to issue non-convertible debentures on a private placement basis aggregating up to Rs 7,500 million. All resolutions received overwhelming support, with approval percentages ranging from 97.77% (Shobana Kamineni's re-appointment) to 99.999% (financial statements and secretarial auditor appointment), on roughly 12.26 crore valid votes cast.

Likely market impact

Routine procedural filing with no negative surprises — all key board re-appointments and the Rs 750 crore NCD borrowing plan have shareholder backing. The strong approval margins suggest stable promoter and institutional support, with no meaningful dissent on capital-raising or governance matters.